Used in biomedical research to quantify PRMT1 enzyme levels in cell or tissue samples, this ELISA kit enables researchers to study protein arginine methylation, a key post-translational modification involved in gene expression, DNA repair, and signal transduction. It is widely applied in epigenetics studies and cancer research, where dysregulation of PRMT1 activity is linked to tumor progression. The kit supports high-throughput screening of potential inhibitors or activators in drug development and helps assess PRMT1 modulation in response to therapeutic agents. Its sensitive and specific detection system makes it valuable for investigating inflammatory diseases, neurological disorders, and metabolic conditions associated with altered methyltransferase activity.